BioBijou Posts 13.4 Billion Won in Q3 Revenue, Highest Quarterly Figure Since Founding View original image

BioBijou, a company specializing in medical aesthetics, posted its highest quarterly revenue since its founding in the third quarter. Its cumulative revenue for this year has also surpassed last year's full-year figure, and the company plans to sustain its growth by expanding overseas sales of its fillers and extracellular matrix (ECM) products next year.


BioBijou said on November 16 that its consolidated revenue for the third quarter was 13.4 billion won, up 36% from the previous quarter and 104% from the same period last year. This was the company's highest quarterly performance since its founding.


Cumulative revenue through the third quarter totaled 31.3 billion won on a consolidated basis. This has already surpassed last year's full-year revenue, marking the company's highest-ever annual performance as well.


Profitability also continued to improve. Third-quarter operating profit was 2.5 billion won on a consolidated basis and 2.7 billion won on a separate basis. Cumulative operating profit through the third quarter was 7.8 billion won on a consolidated basis and 8.3 billion won on a separate basis.


BioBijou is a medical aesthetics company with its own research institute and manufacturing facilities that meet Good Manufacturing Practice (GMP) standards. It is expanding its global business, focusing on skin boosters, fillers, medical cosmetics, and extracellular matrix (ECM) skin revitalizers.


The company expects to significantly expand overseas sales of its fillers after obtaining regulatory approvals in international markets next year. Overseas expansion of Cellivion, its ECM product that is rapidly gaining market share in South Korea, is also expected to gain momentum next year.



BioBijou expects its performance next year to grow even more significantly than this year's, driven by the expansion of its overseas business for fillers and ECM products.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing